אַחֵר

Jones and Somaiah Review the Rationale and Design of the Peak Trial in GIST

0

0

0 צפיות· 09/18/23

OncLive® On Air
0 מנויים

ב

Drs Jones and Somaiah discuss unmet needs in GIST that the Peak trial seeks to answer; the advantages of the methods and design of this trial; and how the tolerable safety profile of bezuclastinib plus sunitinib supports further research with this combination.

להראות יותר

0 הערות

הבא

הפעלה אוטומטית

בית

גלה עוד

עֶזרָה